Relmada Therapeutics (RLMD) - Shares outstanding

Number of shares outstanding as of October 2026 : 112,375,941

According to Relmada Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 112,375,941. At the end of 2026 the company had 112,375,941 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Relmada Therapeutics from 2020 to 2026

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2026	0.11 B	238.57%
2025	33.19 M	10%
2024	30.17 M	0.25%
2023	30.09 M	0.12%
2022	30.06 M	72%
2021	17.47 M	8.94%
2020	16.04 M	64.37%
2019	9.76 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Cytokinetics CYTK	132,086,000	17.54%	🇺🇸 USA
Taro Pharmaceutical TARO	37,584,891	-66.55%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Relmada Therapeutics (RLMD)

Number of shares outstanding as of October 2026 : 112,375,941